Cargando…
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
BACKGROUND: Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death worldwide. The incidence of HCC is affected by genetic and non‐genetic factors. Genetically, mutations in the genes, tumor protein P53 (TP53), catenin beta 1 (CTNNB1), AT‐rich interaction domain 1A (ARIC1A), cyclin...
Autores principales: | Chavda, Vivek, Zajac, Kelsee K., Gunn, Jenna Lynn, Balar, Pankti, Khadela, Avinash, Vaghela, Dixa, Soni, Shruti, Ashby, Charles R., Tiwari, Amit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440848/ https://www.ncbi.nlm.nih.gov/pubmed/37344125 http://dx.doi.org/10.1002/cnr2.1821 |
Ejemplares similares
-
Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes
por: Zajac, Kelsee K., et al.
Publicado: (2023) -
Clinical outcomes of chemotherapy in cancer patients with different ethnicities
por: Pathak, Suhrud, et al.
Publicado: (2023) -
Bridging racial and ethnic disparities in cancer research
por: Sharma, Richa, et al.
Publicado: (2023) -
Trends in participant race and sex reporting in lung cancer phase III clinical trials
por: Aslam, Faaiq N., et al.
Publicado: (2023) -
Pathologically confirmed women's breast cancer: A descriptive study of Tunisian and Algerian series
por: Sassi, Farah, et al.
Publicado: (2023)